Not applicableUnknownNCT03376191What this trial is testingApatinib in Advanced Non-squamous，NSCLCWho this might be right forNon-squamous Non-Small Cell Lung Cancer Jian Fang 100
Testing effectiveness (Phase 2)Study completedNCT00002562What this trial is testingPaclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal CancerWho this might be right forCervical CancerVaginal Cancer Gynecologic Oncology Group 25
Early research (Phase 1)Ended earlyNCT06585488What this trial is testingA First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or AmplificationWho this might be right forMetastatic Solid TumorsAdvanced Non-squamous Non-small-cell Lung CancerAdvanced Colorectal Cancer+4 more BeOne Medicines 47
Testing effectiveness (Phase 2)Study completedNCT00003103What this trial is testingChemotherapy in Treating Patients With Solid TumorsWho this might be right forBladder CancerBreast CancerColorectal Cancer+7 more Memorial Sloan Kettering Cancer Center 57
Testing effectiveness (Phase 2)Looking for participantsNCT07602842What this trial is testingIDP-001 in Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Solid TumorMetastatic Solid TumorHead and Neck Squamous Cell Carcinoma+6 more InduPro, Inc. 132
Post-approval studies (Phase 4)Study completedNCT01609543What this trial is testingTarceva (Erlotinib) in First Line in Patients With Locally Advanced or Metastatic Lung Adenocarcinoma With EGFR MutationsWho this might be right forNon-Squamous Non-Small Cell Lung Cancer Hoffmann-La Roche 62
Testing effectiveness (Phase 2)Ended earlyNCT02109016What this trial is testingAssess the Efficacy and Safety of the VEGFR-FGFR Inhibitor, Lucitanib, Given to Patients With Advanced/Metastatic Lung Cancer and FGF, VEGF, or PDGF Related Genetic AlterationsWho this might be right forNon-Small Cell Lung CancerSquamous Non-Small Cell Lung CancerNSCLC+6 more Clovis Oncology, Inc. 18
Large-scale testing (Phase 3)Looking for participantsNCT06627647What this trial is testingA Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLCWho this might be right forNon-squamous Non-small Cell Lung Cancer AstraZeneca 1,160
Large-scale testing (Phase 3)UnknownNCT02643407What this trial is testingNedaplatin/Docetaxel Versus Cisplatin/Docetaxel in Treatment of Advanced/Relapsed Squamous Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer Guangdong Association of Clinical Trials 488
Early research (Phase 1)Looking for participantsNCT05877599What this trial is testingNT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H MutationWho this might be right forNon-small Cell Lung CancerHead and Neck Squamous Cell CarcinomaColorectal Carcinoma+5 more AstraZeneca 45
Not applicableStudy completedNCT01836133What this trial is testingAn Observational Study of Tarceva (Erlotinib) in Participants With Locally Advanced or Metastatic Adenocarcinoma Non-Small Cell Lung Cancer (ELEMENT)Who this might be right forNon-Squamous Non-Small Cell Lung Cancer Hoffmann-La Roche 70
Early research (Phase 1)UnknownNCT02637531What this trial is testingA Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549Who this might be right forAdvanced Solid Tumors (Part A/B/C/D)Non-small Cell Lung Cancer (Part E)Melanoma (Part E)+5 more Infinity Pharmaceuticals, Inc. 219
Large-scale testing (Phase 3)Study completedNCT03196986What this trial is testingMil60 Versus Bevacizumab in Patients With Treatment-naïve Non-squamous Non-small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer Beijing Mabworks Biotech Co., Ltd. 517
Not applicableActive Not RecruitingNCT07485166What this trial is testingEmulation of the CheckMate 017/057 (NCT01642004 and NCT01673867) Trials Using Specialty Oncology Electronic Health Records DatabasesWho this might be right forAdvanced Non-squamous Non-small-cell Lung CancerAdvanced Squamous Non Small Cell Lung Cancer Brigham and Women's Hospital 810
Testing effectiveness (Phase 2)Study completedNCT01948141What this trial is testingNintedanib in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Up to Two Previous Chemotherapy RegimensWho this might be right forRecurrent Non-small Cell Lung CancerSquamous Cell Lung CancerStage III Non-small Cell Lung Cancer+1 more Roswell Park Cancer Institute 6
Testing effectiveness (Phase 2)Ended earlyNCT00807612What this trial is testingQUILT-2.017: Phase 1b/2 Study of AMG 479 in Combination With Paclitaxel and Carboplatin for 1st Line Treatment of Advanced Squamous Non-Small Cell Lung CancerWho this might be right forAdvanced Squamous Non-Small Cell Lung Cancer NantCell, Inc. 15
Large-scale testing (Phase 3)Study completedNCT01631136What this trial is testingStrategies for Maintenance Therapies in Advanced Non Small Cell Lung CancerWho this might be right forAdvanced Non Small Cell Lung Cancer Intergroupe Francophone de Cancerologie Thoracique 932
Large-scale testing (Phase 3)Study completedNCT00020709What this trial is testingCombination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By SurgeryWho this might be right forAdenocarcinoma of the LungBronchoalveolar Cell Lung CancerLarge Cell Lung Cancer+3 more National Cancer Institute (NCI) 840
Testing effectiveness (Phase 2)Study completedNCT00087412What this trial is testingS0341: Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung CancerWho this might be right forAdenocarcinoma of the LungLarge Cell Lung CancerRecurrent Non-small Cell Lung Cancer+3 more National Cancer Institute (NCI) 65
Early research (Phase 1)Ended earlyNCT02437916What this trial is testingSafety Study of AMG 228 to Treat Solid TumorsWho this might be right forAdvanced MalignancyAdvanced Solid TumorsCancer+8 more Amgen 30